Chen, R., Zinzani, P. L., Fanale, M. A., Armand, P., Johnson, N. A., Brice, P., . . . Moskowitz, C. H. (2017). Phase II Study of the Efficacy and Safety of Pembrolizumab for Relapsed/Refractory Classic Hodgkin Lymphoma. J Clin Oncol.
Citação norma ChicagoChen, Robert, et al. "Phase II Study of the Efficacy and Safety of Pembrolizumab for Relapsed/Refractory Classic Hodgkin Lymphoma." J Clin Oncol 2017.
MLA CitationChen, Robert, et al. "Phase II Study of the Efficacy and Safety of Pembrolizumab for Relapsed/Refractory Classic Hodgkin Lymphoma." J Clin Oncol 2017.
Advarsel: Disse citationer er muligvist ikke 100% nøjagtige.